Share on StockTwits

Shares of Ampio Pharmaceuticals (NYSE:AMPE) were the target of a significant increase in short interest in August. As of August 15th, there was short interest totalling 7,325,307 shares, an increase of 14.4% from the July 31st total of 6,403,259 shares, AnalystRatingsNetwork.com reports. Currently, 15.1% of the company’s shares are short sold. Based on an average daily volume of 525,809 shares, the days-to-cover ratio is currently 13.9 days.

Separately, analysts at Jefferies Group initiated coverage on shares of Ampio Pharmaceuticals in a research note on Friday, June 27th. They set a “buy” rating and a $14.00 price target on the stock.

Shares of Ampio Pharmaceuticals (NYSE:AMPE) traded down 3.94% on Tuesday, hitting $4.87. 1,811,916 shares of the company’s stock traded hands. Ampio Pharmaceuticals has a 1-year low of $4.82 and a 1-year high of $10.86. The stock’s 50-day moving average is $6.51 and its 200-day moving average is $6.92. The company’s market cap is $253.1 million.

Ampio Pharmaceuticals, Inc (NYSE:AMPE) is a development-stage biopharmaceutical company focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.